Ghana’s Food and Drugs Authority has approved the vaccine’s use in children aged between five months to three years as the west African country strengthens its efforts to control malaria-related child mortality. Around 20,000 children die of malaria every year in Ghana, 25% of whom are aged under five. An Oxford University-developed vaccine against malaria has been approved and cleared for use in Ghana, its first such approval in the world. Do you trust the world vaccines considering how the Covid-19 vaccines has affected the human health ?